LGBTQ+ Healthcare Specific Medical Interventions

Attitudes, Beliefs, and Barriers to PrEP Among Trans Men

  • The study examined the attitudes and knowledge of transgender men (trans men) regarding pre-exposure prophylaxis (PrEP) for HIV.

Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men

  • Integrated knowledge regarding pre-exposure prophylaxis (PrEP) awareness and willingness to use PrEP can be useful for HIV prevention in high incidence groups. This review summarizes the awareness of PrEP and willingness to use PrEP among men who have sex with men (MSM).

'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women

  • The frequent conflation of transgender (‘trans’) women with ‘men who have sex with men (MSM)’ in HIV prevention obscures trans women’s unique gender identities, social and behavioral vulnerabilities, and their disproportionately high rates of HIV infection.

Building Racial and Gender Equity into a National PrEP Access Program

  • This commentary provides additional context and recommendations to maximize effectiveness of a national PrEP program for TGD, Black, and Latinx populations in the US

Gender-affirming hormone therapy: An updated literature review with an eye on the future

  • Hormonal regimens have changed over time, and older data may be less relevant for today's practice. In recent literature, we have found that even though mental health problems are more prevalent in trans people compared to cisgender people, less psychological difficulties occur, and life satisfaction increases with gender-affirming hormone treatment (GAHT) for those who feel this is a necessity.

Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review

Monitoring Long-Term Cardiovascular Risk from Estrogen Use in Transgender Women - Evidence Update for Clinicians

  • A PCORI-funded study provides new information for primary care clinicians about the need to monitor long-term cardiovascular risks in transgender women receiving hormone therapy.

Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy

  • The objective of this narrative review was to characterise the influence of GAHT on body composition and bone health in the transgender population to help address weight concerns and chronic disease risk.

Current use of testosterone therapy in LGBTQ populations

  • Testosterone therapy (TT) is a type of gender-affirming hormone therapy (GAHT) in lesbian, gay, bisexual, transgender, and genderqueer (LGBTQ) populations for gender dysphoria (GD), body uneasiness, and sexual dysfunction.

Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals

  • Recent studies show that DWI also allows for assessing neuroplastic adaptations in the human hypothalamus. To this end, we investigated a potential influence of testosterone replacement therapy on hypothalamic microstructure in female-to-male (FtM) transgender individuals.

Masculinizing gender-affirming surgery for trans men and non-binary individuals: what you should know

  • In this review, we describe the common procedures comprising masculinizing GAS to improve delivery of specialized care for this patient population.